Literature DB >> 24880807

An integrated membrane system for the biocatalytic production of 3'-sialyllactose from dairy by-products.

Jianquan Luo1, Rune T Nordvang2, Sofie T Morthensen2, Birgitte Zeuner2, Anne S Meyer2, Jørn Dalgaard Mikkelsen2, Manuel Pinelo3.   

Abstract

An integrated membrane system was investigated for the production of 3'-sialyllactose by an engineered sialidase using casein glycomacropeptide (CGMP) and lactose as substrates. CGMP was purified by ultrafiltration (UF) to remove any small molecules present and then an enzymatic membrane reactor (EMR) was used to separate the product and reuse the enzyme. A PLCC regenerated cellulose membrane was found to be the most suitable for both the UF purification and EMR. Subsequently, nanofiltration (NF) was conducted to increase the purity of the 3'-sialyllactose by removing the excess lactose present. The NTR7450 membrane outperformed others in NF due to its high retention of 3'-sialyllactose (98%) and relatively low rejection of lactose (40%). The lactose in the permeate could be concentrated by the NF45 membrane and recycled into the EMR. The described integrated membrane system enables a more economic and efficient enzymatic production of 3'-sialyllactose.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EMR; Enzyme; Human milk oligosaccharides; Nanofiltration; Ultrafiltration

Mesh:

Substances:

Year:  2014        PMID: 24880807     DOI: 10.1016/j.biortech.2014.05.003

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  8 in total

1.  3'-Sialyllactose protects against osteoarthritic development by facilitating cartilage homeostasis.

Authors:  Jimin Jeon; Li-Jung Kang; Kwang Min Lee; Chanmi Cho; Eun Kyung Song; Wook Kim; Tae Joo Park; Siyoung Yang
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

2.  Design of Trypanosoma rangeli sialidase mutants with improved trans-sialidase activity.

Authors:  Christian Nyffenegger; Rune Thorbjørn Nordvang; Carsten Jers; Anne S Meyer; Jørn Dalgaard Mikkelsen
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

3.  3'-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis.

Authors:  Li-Jung Kang; Eun-Soo Kwon; Kwang Min Lee; Chanmi Cho; Jae-In Lee; Young Bae Ryu; Tae Hyun Youm; Jimin Jeon; Mi Ra Cho; Seon-Yong Jeong; Sang-Rae Lee; Wook Kim; Siyoung Yang
Journal:  Br J Pharmacol       Date:  2018-10-17       Impact factor: 8.739

4.  3'-Sialyllactose Protects SW1353 Chondrocytic Cells From Interleukin-1β-Induced Oxidative Stress and Inflammation.

Authors:  Ahreum Baek; So Hee Jung; Soonil Pyo; Soo Yeon Kim; Seongmoon Jo; Lila Kim; Eun Young Lee; Sung Hoon Kim; Sung-Rae Cho
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

5.  Marine-Derived Biowaste Conversion into Bioceramic Membrane Materials: Contrasting of Hydroxyapatite Synthesis Methods.

Authors:  Yusuf Wibisono; Alien Yala Pratiwi; Christine Ayu Octaviani; Cut Rifda Fadilla; Alfian Noviyanto; Epi Taufik; Muhammad K H Uddin; Fajri Anugroho; Nurul Taufiqu Rochman
Journal:  Molecules       Date:  2021-10-20       Impact factor: 4.411

6.  Therapeutic effect of intra-articular injected 3'-sialyllactose on a minipig model of rheumatoid arthritis induced by collagen.

Authors:  Young June Kim; Ju-Young Lee; Mi-Jin Yang; Hyun Jin Cho; Min-Young Kim; Lila Kim; Jeong Ho Hwang
Journal:  Lab Anim Res       Date:  2022-03-22

7.  It All Starts with a Sandwich: Identification of Sialidases with Trans-Glycosylation Activity.

Authors:  Rune T Nordvang; Christian Nyffenegger; Jesper Holck; Carsten Jers; Birgitte Zeuner; Ulrik K Sundekilde; Anne S Meyer; Jørn D Mikkelsen
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

8.  3'-Sialyllactose prebiotics prevents skin inflammation via regulatory T cell differentiation in atopic dermatitis mouse models.

Authors:  Li-Jung Kang; Eunjeong Oh; Chanmi Cho; HoKeun Kwon; Choong-Gu Lee; Jimin Jeon; Hyemi Lee; Sangil Choi; Seong Jae Han; Jiho Nam; Chi-Une Song; Hyunho Jung; Hye Young Kim; Eun-Jung Park; Eun-Ju Choi; Jooyoung Kim; Seong-Il Eyun; Siyoung Yang
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.